BioMarin (BMRN) Buy Rating Maintained at BofA/Merrill Lynch; FDA Vote Suggests Drisapersen Efficacy Was 'Inconclusive'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. IRT
6. QCOM
7. ASO
8. SPY
9. EVMN
10. AAPL

Go back to BioMarin (BMRN) Buy Rating Maintained at BofA/Merrill Lynch; FDA Vote Suggests Drisapersen Efficacy Was 'Inconclusive'
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 64.56 -0.07 (0.11%)
Previous Close $64.63    52 Week High $108.96 
Open $63.83    52 Week Low $62.12 
Day High $65.31    P/E N/A 
Day Low $63.64    EPS $-1.27 
Volume 317,241